1. Home
  2. HRMY vs DNOW Comparison

HRMY vs DNOW Comparison

Compare HRMY & DNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • DNOW
  • Stock Information
  • Founded
  • HRMY 2017
  • DNOW 1862
  • Country
  • HRMY United States
  • DNOW United States
  • Employees
  • HRMY N/A
  • DNOW N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • DNOW Metal Fabrications
  • Sector
  • HRMY Health Care
  • DNOW Industrials
  • Exchange
  • HRMY Nasdaq
  • DNOW Nasdaq
  • Market Cap
  • HRMY 2.2B
  • DNOW 1.8B
  • IPO Year
  • HRMY 2020
  • DNOW N/A
  • Fundamental
  • Price
  • HRMY $34.56
  • DNOW $17.43
  • Analyst Decision
  • HRMY Strong Buy
  • DNOW Buy
  • Analyst Count
  • HRMY 8
  • DNOW 2
  • Target Price
  • HRMY $54.38
  • DNOW $17.00
  • AVG Volume (30 Days)
  • HRMY 557.4K
  • DNOW 1.1M
  • Earning Date
  • HRMY 02-25-2025
  • DNOW 02-13-2025
  • Dividend Yield
  • HRMY N/A
  • DNOW N/A
  • EPS Growth
  • HRMY N/A
  • DNOW N/A
  • EPS
  • HRMY 2.11
  • DNOW 0.74
  • Revenue
  • HRMY $681,879,000.00
  • DNOW $2,373,000,000.00
  • Revenue This Year
  • HRMY $25.11
  • DNOW $1.14
  • Revenue Next Year
  • HRMY $19.19
  • DNOW $4.17
  • P/E Ratio
  • HRMY $16.46
  • DNOW $23.47
  • Revenue Growth
  • HRMY 25.83
  • DNOW 2.24
  • 52 Week Low
  • HRMY $28.14
  • DNOW $11.42
  • 52 Week High
  • HRMY $41.61
  • DNOW $18.45
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 35.54
  • DNOW 72.35
  • Support Level
  • HRMY $37.03
  • DNOW $16.98
  • Resistance Level
  • HRMY $39.91
  • DNOW $18.45
  • Average True Range (ATR)
  • HRMY 1.34
  • DNOW 0.65
  • MACD
  • HRMY -0.58
  • DNOW 0.28
  • Stochastic Oscillator
  • HRMY 9.86
  • DNOW 77.30

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

Share on Social Networks: